124 related articles for article (PubMed ID: 11170283)
21. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
[TBL] [Abstract][Full Text] [Related]
22. Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy.
Seymour JF; Juneja SK; Campbell LJ; Ellims PH; Estey EH; Prince HM
Leukemia; 1999 Nov; 13(11):1735-40. PubMed ID: 10557046
[TBL] [Abstract][Full Text] [Related]
23. Trisomy 4 and de novo acute myelomonocytic leukemia in a Kuwaiti patient.
al-Bahar S; Pandita R; Owade JM; al Aasar EM
Cancer Genet Cytogenet; 1993 Jul; 68(2):147-8. PubMed ID: 8353807
[TBL] [Abstract][Full Text] [Related]
24. [Additional chromosomal abnormality of inv(16)(p13q22) to del(7)(q32) in a patient with acute myelomonocytic leukemia].
Ida T; Hashimoto S; Yano T; Sato N; Koike T
Rinsho Ketsueki; 2012 Mar; 53(3):347-51. PubMed ID: 22499053
[TBL] [Abstract][Full Text] [Related]
25. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
[TBL] [Abstract][Full Text] [Related]
26. Recurrent cytogenetic abnormalities observed in complete remission of acute myeloid leukemia do not necessarily mark preleukemic cells.
Raynaud SD; Brunet B; Chischportich M; Bayle J; Gratecos N; Pesce A; Dujardin P; Flandrin G; Ayraud N
Leukemia; 1994 Feb; 8(2):245-9. PubMed ID: 8309249
[TBL] [Abstract][Full Text] [Related]
27. Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia.
Heyll A; Aul C; Gogolin F; Runde V; Söhngen D; Meckenstock G; Wolf HH; Zahner J; Burk M; Winkelmann M
Ann Hematol; 1994 Jun; 68(6):279-83. PubMed ID: 8038233
[TBL] [Abstract][Full Text] [Related]
28. Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
Assi R; Kantarjian HM; Kadia TM; Pemmaraju N; Jabbour E; Jain N; Daver N; Estrov Z; Uehara T; Owa T; Cortes JE; Borthakur G
Cancer; 2018 Jul; 124(13):2758-2765. PubMed ID: 29660836
[TBL] [Abstract][Full Text] [Related]
29. A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4).
Bernasconi P; Cavigliano PM; Boni M; Malcovati L; Calatroni S; Astori C; Caresana M; Bernasconi C
Leukemia; 1999 Mar; 13(3):487-9. PubMed ID: 10086743
[No Abstract] [Full Text] [Related]
30. [A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype].
Kim M; Lee JW; Lee JK; Hong YJ; Hong SI; Kang HJ; Cho EH; Chang YH
Korean J Lab Med; 2010 Aug; 30(4):329-33. PubMed ID: 20805702
[TBL] [Abstract][Full Text] [Related]
31. Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML).
Advani AS; Li H; Michaelis LC; Medeiros BC; Liedtke M; List AF; O'Dwyer K; Othus M; Erba HP; Appelbaum FR
Leuk Res; 2018 Apr; 67():17-20. PubMed ID: 29407182
[TBL] [Abstract][Full Text] [Related]
32. Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia.
Shi G; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1993 Oct; 70(2):140-1. PubMed ID: 8242596
[TBL] [Abstract][Full Text] [Related]
33. Isochromosome (X)(p10) in hematologic disorders: FISH study of 14 new cases show three types of centromere signal patterns.
Adeyinka A; Smoley S; Fink S; Sanchez J; Van Dyke DL; Dewald G
Cancer Genet Cytogenet; 2007 Nov; 179(1):25-30. PubMed ID: 17981211
[TBL] [Abstract][Full Text] [Related]
34. FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia.
Nørgaard JM; Olesen LH; Olesen G; Meyer K; Kristensen JS; Bendix K; Pedersen B; Kjeldsen E; Hokland P
Eur J Haematol; 2001 Oct; 67(4):221-9. PubMed ID: 11860442
[TBL] [Abstract][Full Text] [Related]
35. Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia.
Archimbaud E; Jehn U; Thomas X; De Cataldo F; Fillet G; Belhabri A; Peaud PY; Martin C; Amadori S; Willemze R
Leukemia; 1999 Jun; 13(6):843-9. PubMed ID: 10360370
[TBL] [Abstract][Full Text] [Related]
36. Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses.
Nawata R; Shinohara K; Yamada T; Takahashi T; Katsuki K; Takeda K; Kameda N; Ariyoshi K; Ota I; Muraki K
Int J Hematol; 2000 Jun; 71(4):353-8. PubMed ID: 10905055
[TBL] [Abstract][Full Text] [Related]
37. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
[TBL] [Abstract][Full Text] [Related]
38. Isochromosome 7q in Down syndrome.
Wong KF; Lam SC; Leung JN
Cancer Genet Cytogenet; 2006 Jan; 164(2):152-4. PubMed ID: 16434320
[TBL] [Abstract][Full Text] [Related]
39. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
Liu J; Mi Y; Fu M; Yu W; Wang Y; Lin D; Bian S; Wang J
Am J Hematol; 2009 Jul; 84(7):422-7. PubMed ID: 19484734
[TBL] [Abstract][Full Text] [Related]
40. Inv(4)(p14q27) in a case with de novo acute nonlymphocytic leukemia.
Benasayag S; Arias E; Baialardo E; Reyes M; Sapia S; Bistmans A; Slavutsky I
Acta Haematol; 2002; 108(1):39-42. PubMed ID: 12145466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
